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Abstract
Background. The p38 mitogen-activated protein kinase
(p38 MAPK) is an important intracellular signal trans-
duction pathway involved in TGF-β1-induced epithelial–
mesenchymal transition (EMT). Sema4C, a member of
the semaphorin family, was found to be essential for the ac-
tivation of p38 MAPK. However, the role of Sema4C in
promoting TGF-β1-induced EMT is unclear.
Methods. Renal fibrosis was induced by 5/6 subtotal neph-
rectomy rat model. In vitro, Sema4C was induced in human
proximal tubular epithelial cells (HKC) by treatment with
TGF-β1, or was inhibited by siRNA or was over-expressed
by Sema4C transfection. The selective p38 MAPK inhibi-
tor, SB203580, was administered to inhibit the p38 path-
way. The expression of Sema4C, the markers of EMT,
p38 phosphorylation and fibronectin secretion were mea-
suredbywesternblotting,immunohistochemistry,immuno-
cytochemistry or enzyme-linked immunosorbent assay.
Results. The expression of Sema4C increased in HKC
cells that were treated with TGF-β1. Knockdown of Se-
ma4C potently inhibited phosphorylation of p38 MAPK
and reversed TGF-β1-induced EMT. Over-expression of
Sema4C via Sema4C transfection elicited p38 MAPK
phosphorylation and promoted EMT. The effects of Se-
ma4C during EMT were blocked by a p38-specific in-
hibitor. In vivo, the expression of Sema4C increased in
the tubular epithelia of 5/6-nephrectomized rats and hu-
man fibrotic renal tissue, and similar localization of
phosphorylated p38 and Sema4C was demonstrated by
immunohistochemistry on serial sections.
Conclusions. Our findings suggest that Sema4C plays an
important role in TGF-β1-induced EMT through activa-
tion of p38 MAPK in proximal tubular epithelial cells.
Keywords: epithelial to mesenchymal transition; p38 MAPK; Sema4C;
TGF-β1
Introduction
The progression of chronic kidney disease leads to wide-
spread tissue fibrosis and irreversible loss of renal func-
tion. Epithelial–mesenchymal transition (EMT) of tubular
epithelial cells contributes significantly to the onset and
pathogenesis of renal fibrosis [1–4]. An extracellular
stimulus usually initiates this process, which leads to the
loss of junctional contacts, expression of mesenchymal
markers, development of cell motility and production of
extracellular matrix (ECM) [2,5]. Of the many factors that
trigger EMT, transforming growth factor-β1 (TGF-β1) is
the most important and well studied [6]. TGF-β1 mediates
the EMT process via numerous intracellular signal trans-
duction pathways, including the canonical Smad pathway,
mitogen-activated protein kinases (MAPK), PI3K/Akt and
small GTPases that control the activity or expression of
factors related to EMT [7,8].
In recent years, significant evidence suggests that p38
MAPK pathway is an important intracellular signal trans-
duction pathway involved in TGF-β1-induced EMT in
renal tubular epithelial cells [9,10]. The activated p38
MAPK could directly regulate the protein synthesis of α-
smooth muscle cell actin (α-SMA) [10], indirectly activate
Smad pathway [9], lead to excessive matrix deposition and
finally induce the fibrotic process. However, the molecular
details of how TGF-β1 could potentially induce p38
MAPK in renal tubular cells have not been elucidated yet.
Sema4C, a member of the semaphorin family, has been
shown to be essential for the activation of p38 MAPK [11].
The semaphorins are a large family of secreted or mem-
brane-bound proteins that all have a conserved Sema do-
main, which is known to regulate tumor progression [12],
angiogenesis [13], nervous system development [14] and
immune cell interactions [15]. Our previous microarray
analysis of metastatic human cervical cancer tissue indi-
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provided the original work is properly cited.cated a significant up-regulation of Sema4C during cancer
invasion and metastasis (Table 1; this data had not been
published elsewhere), a process that is analogous to that
observed during tubular EMT [6,16]. However, it is not
known whether Sema4C is involved in EMT. We therefore
examined whether TGF-β1-induced EMT is mediated by
Sema4C–MAPK pathway. For this purpose, we measured
Sema4C in the tubular epithelia of fibrotic renal tissue and
in renal tubular cells treated with TGF-β1, examined the
effect of Sema4C siRNA on TGF-β1-induced MAPK ac-
tivation, EMT and fibronectin secretion, and measured the
p38 phosphorylation and EMT in Sema4C over-expressed
cells.
Materials and methods
Animal model
Male Sprague–Dawley rats (150–200 g) were obtained from the Tongji
Laboratory Animal Center (Wuhan, China). All rats were sacrificed
20 weeks after nephrectomy, and serum was collected for determination
of creatinine and urea nitrogen. Kidneys were immediately excised; some
were fixed with 4% paraformaldehyde and others were frozen in liquid ni-
trogenfor later use.Forhistologicalexamination,renal tissueswerestained
withperiodicacid–SchiffandMasson'strichrome.Allprocedureswereper-
formed in accordance with our university’s guidelines for animal care.
Cell cultures
HKC cells were cultured in DMEM/F12 (Invitrogen, Inc., Carlsbad, CA,
USA) supplemented with 10% fetal bovine serum (Gibco, USA). HKC
cells were cultured in serum-free medium for 24 h before being used
for experiments. To induce renal tubular EMT, cells were then treated with
recombinant TGF-β1 (10 ng/mL; B&D Systems Inc., Minneapolis, MN,
USA) for 72 h.
SiRNA for Sema4C
For siRNA experiments, RNA primers complementary to human Sema4C
were designed and synthesized by the Shanghai Invitrogen Biotechnology
Company. HKC cells were transfected with the annealed RNA primer pair
by using Lipofectamine 2000 (Invitrogen Inc.), according to the manufac-
turer's instructions. Five hours after transfection, cells were incubated with
10 ng/mL of TGF-β1 for 72 h to observe the effect of Sema4C silencing.
Production of stable HKC clones over-expressing human Sema4C
The plasmid pcDNA 4.0–Sema4C was transfected into HKC cells with
Lipofectamine 2000 according to the manufacturer's instructions. Cells
were plated at ~70–90% confluence in six-well plates 1 day before
transfection. The cells were washed and seeded in growth medium con-
taining zeocin. This selection procedure lasted for 2 weeks, and then
Zeocin-resistant clones were harvested and analysed. To block the p38
MAPK pathway, Sema4C-transfected HKC cells were treated with
20 mM SB203580 for 48 h.
Western blotting
Kidney tissues and cells were extracted with lysis buffer containing 1%
Triton X-100, 0.5% Nonidet P-40, 20 mM Tris–HCl, 15 mM NaCl,
1 mmol/L EDTA, 1 mmol/L egtazic acid, 1 mM Na3VO4·10H2O, 2 mM
NaF, 2 mM Na2P2O4·10H2O, 10 mM β-glycerophosphate disodium salt
(pH 8.0) and four protease inhibitors (5 mM phenylmethanesulfonyl fluor-
ide, 5 μg/mL leupeptin, 5 μg/mL pepstatin and 5 μg/mL aprotinin) for
30 min at −20°C. Then, the extract was centrifuged at 12 000 g for
20 min at 4°C to remove cell debris. Protein concentration was deter-
mined by the Bradford protein assay, 80 μg of protein was subjected to
SDS–PAGE and proteins were transferred to nitrocellulose membranes.
After transfer, the membranes were blocked with 5% non-fat dry milk
dissolved in TBS containing 0.1% Tween-20 for 1 h at 37°C and blotted
routinely with Sema4C (BD Biosciences, San Jose, CA, USA), E-cadherin
(BD Biosciences), vimentin (Abcam, Cambridge, MA, USA), GAPDH
(Proteintech Group, Inc.), phosphorylated p38 MAPK and p38 primary
antibodies (Cell Signaling Technology, Danvers, MA, USA) at 37°C for
1 h. The bound antibody complexes were visualized by enhanced chemi-
luminescence (SuperSignal West Femto Kit; Pierce, Rockford, IL, USA),
and X-ray films were scanned with a ChemiImager 5500 image analysis
system (Alpha Innotech, San Leandro, CA, USA). Quantity One software
(Bio-Rad) was used to quantify band density.
Renal biopsy specimens
Renal biopsy specimens were from patients with sclerosing glomerulo-
nephritis or obstructive nephropathy, diagnosed between 2008 and 2010
in the Division of Nephrology, Tongji Hospital, Tongji Medical College,
Huazhong University of Science and Technology. Informed consent was
obtained from each patient when the renal biopsy was performed. The
research was in compliance with the Declaration of Helsinki. In all of
the renal biopsy specimens, the tubulointerstitial fibrosis was dominant.
Immunohistochemistry and immunocytochemistry
For immunohistochemical analysis, paraffin sections or serial sections
were incubated with either primary anti-Sema4C antibody or phosphory-
lated p38 MAPK antibody at 4°C overnight. The sections were then in-
cubated with biotinylated goat anti-mouse Ig antibody as the secondary
antibody, and the antibody reactions were visualized by using diamino
benzidine (DAKO, Tokyo, Japan). The serial sections were then analysed
to clarify the colocalization of Sema4C and phosphorylated p38 MAPK in
these kidneys.
For immunocytochemical analysis, HKC cells were cultured on sterile
glass coverslips in six-well plates. The slides were incubated overnight at
4°C with anti-E-cadherin, anti-vimentin or anti-phosphorylated p38 anti-
body, followed by incubation with FITC-conjugated secondary antibody at
room temperature for 1 h. Finally, slides were counterstained with propi-
dium iodide for E-cadherin, DAPI for vimentin and visualized by confocal
laser scanning microscopy.
ELISA assay
Fibronectin (FN) secretion was determined by a competitive ELLSA
assay kit (Boster Biological Technology, Wuhan, China) according to
the manufacturer's instructions. The OD value was detected by an ELISA
Reader in 450-nm wavelength and calculated in the linear part of the
curve.
Statistical analyses
All data were analysed by Student’s t-test or a one-way ANOVA using
SPSS (version 12.0). Data are expressed as means ± standard errors of
the mean (SEM). Significance was assessed at P < 0.05.
Table 1. Genes up-regulated in metastatic human cervical cancer tissue
Probe set ID Gene symbol Description P-value
46665_at Sema4c Nervous system and cell differentiation development 0.000219
217022_s_at IGHA1 Immune response, protein–chromophore linkage 0.000052
221748_s_at TNS1 Intracellular signalling cascade 0.000147
229152_at C4orf7 Chromosome 4 open reading frame 7 0.001953
234379_at FLT-4 Protein–tyrosine kinase activity and receptor activity 0.01421
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Sema4C is involved in renal fibrosis in vivo
First, we examined the distribution of Sema4C in the fi-
brotic kidney by use of the 5/6 subtotal nephrectomy rat
model. As shown in Table 2, serum urea nitrogen and cre-
atinine were significantly elevated in 5/6-nephrectomized
rats compared with sham-operated rats. Light microscopy
indicated glomerular sclerosis and interstitial fibrosis in
the 5/6-nephrectomized rats, but not in the sham-operated
rats (Figure 1A).
Immunohistochemical staining showedthat Sema4C was
mainly expressed in renal tubular cells of 5/6-nephrecto-
mized rats, with very little staining in the renal tubules of
sham-operated rats (Figure 1B). Western blotting also in-
dicated that Sema4C protein expression was significantly
elevated in the kidney of 5/6-nephrectomized rats com-
pared with sham-operated rats (Figure 1C). These results
suggest that Sema4C is involved in renal fibrosis in this
animal model.
TGF-β1 increases the expression of Sema4C in HKC cells
and Sema4C depletion inhibits TGF-β1-induced EMT
Tubular epithelial cells are the natural targets of TGF-β1 in
vivo, which plays a critical role in renal fibrosis in the 5/6
subtotal nephrectomy rat model [17]. Therefore, we exam-
ined the expression of Sema4C in proximal epithelial cells
(HKC cells) that were treated with TGF-β1 in vitro. The
result indicates that Sema4C was significantly elevated
in HKC cells after incubation for 72 h with 10 ng/mL
TGF-β1 (Figure 2A).
We also investigated whether Sema4C could affect
TGF-β1-dependent EMT by use of siRNA experiments.
As shown in Figure 2A, cells developed EMT after 72 h
of incubation with TGF-β1. This was manifested as
down-regulation of E-cadherin, an epithelial marker, the
decrease of which is a hallmark of EMT. In contrast, the
proteinvimentin, a mesenchymal marker, was up-regulated
in TGF-β1-treated cells as compared with control cells
(Figure 2A).
Confocal laser microscopy showed that E-cadherin had
a continuous distribution near the perimeter of control
cells [Figure 2B (I)], but had a discontinuous distribution
near the perimeter of TGF-β1-treated cells [Figure 2B
(II)]. Vimentin was present exclusively in the cytosol of
TGF-β1-treated cells [Figure 2B (V)], and there was little
endogenous expression in control cells [Figure 2B (IV)].
HKC cells transfected with Sema4C-specific siRNA
were resistant to TGF-β1-induced EMT. As shown in
Figure 2A, Sema4C after silencing almost touched the ba-
sal level, which is about 62% lower than that of TGF-β1-
treated cells. The EMT resistance manifested as elevated
levels of E-cadherin protein (Figure 2A), relocalization
of E-cadherin protein to the cell perimeter [Figure 2B
Table 2. Renal function in sham-operated rats and 5/6-nephrectomized
rats
Groups n Bun (mmol/L) Scr (μmol/L)
Sham-operated 8 6.25 ± 1.02 27.13 ± 6.13
5/6-nephrectomized 8 36.79 ± 15.93* 125.29 ± 58.35*
*P < 0.01 compared with sham-operated rats.
Bun, serum urea nitrogen; Scr, serum creatinine.
Fig. 1. Expression of Sema4C is increased in the kidney tissue of 5/6
nephrectomized rats. (A) Representative histology of kidney sections
from sham-operated and 5/6-nephrectomized (5/6 NX) rats stained with
periodic acid–Schiff (upper) or Masson's trichrome stain (lower).
Interstitial fibrosis and glomerular sclerosis are extensive in 5/6 NX
rats. The tissue of sham rats was normal. Magnification ×200. (B)
Representative immunohistochemical detection of Sema4C in the
kidney tissue of sham-operated and 5/6-nephrectomized rats. Sema4C
immunostaining is strong in the epithelial tubular cells in 5/6 NX rats
and much weaker in sham rats. Magnification ×200. (C) Representative
western blot of Sema4C in the kidney tissue of sham-operated and 5/6-
nephrectomized rats. The expression of the Sema4C protein was elevated
in the kidney tissue of 5/6-nephrectomized rats. The histogram shows the
average volume density corrected for the loading control, GAPDH
(n = 6). *P < 0.05 compared with sham-operated rats.
Sema4C mediates TGF-β1 stimulation of EMT via p38 MAPK 1151(III)] and reduced vimentin expression compared with
TGF-β1-treated cells [Figure 2A and 2B (VI)]. All of these
results suggest that Sema4C depletion inhibits TGF-β1-
induced EMT.
As accumulated interstitial matrix components were a
consequence of EMT, fibronectin secretion by HKC cells
was measured in culture supernatants. Treatment of HKC
cells for 72 h with TGF-β1 resulted in a significant mean
3.8-fold increase (N = 4) in fibronectin protein compared
with control cells (Figure 2C). HKC cells transfected with
Sema4C-specific siRNAwere resistant to TGF-β1-induced
fibronectin secretion (Figure 2C). This result was consist-
ent with the finding that Sema4C depletion prevented
TGF-β1-induced EMT.
Sema4C is an activator of p38 MAPK in TGF-β1-induced
EMT
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MAPK pathway signalling [11]. To investigate whether
Sema4C is involved in the TGF-β1-induced EMT through
the activation of p38 MAPK, we examined the phosphor-
ylation of p38 MAPK in TGF-β1-treated cells. Western
blotting showed that TGF-β1 significantly increased phos-
phorylation of p38 MAPK in HKC cells after 72 h of treat-
ment (Figure 3). The phosphorylated p38 was about 2-fold
higher than that of control, and it could be strikingly inhib-
ited, almost to basal level, by Sema4C-specific siRNA
(Figure 3).
Next, we examined the phosphorylation of p38 and
mesenchymal phenotype in Sema4C-transfected HKC
cells. The results confirmed high expression of Sema4C
and p38 phosphorylation and typical mesenchymal pheno-
type in Sema4C-transfected cells (Figure 4). As shown in
Figure 4B, Sema4C transfection significantly increased the
phosphorylation of p38 MAPK. Treatment with SB203580
(a p38 MAPK inhibitor) decreased phosphorylation of p38
MAPK by 31% (Figure 4B). Confocal laser microscopy
showed that E-cadherin was linearly localized at cell bor-
ders of control cells [Figure 4C (I)], but formed a zipper-
like pattern near the perimeter of Sema4C-transfected cells
[Figure 4C (II)]. Vimentin was present exclusively in the
cytosol of Sema4C-transfected cells [Figure 4C (V)], and
there was little endogenous expression in control cells
Fig. 2. Expression of Sema4C is increased in TGF-β1-treated cells, and depletion of Sema4C represses TGF-β1-induced EMT. (A) Representative
western blot of Sema4C, E-cadherin and vimentin in control cells, TGF-β1-treated cells and TGF-β1-treated Sema4C-siRNA cells. The histogram
shows the average volume density corrected for the loading control, GAPDH (n = 4). *P < 0.05 compared with control cells.
#P < 0.05 compared
with TGF-β1-treated cells. (B) Representative confocal microscopy of E-cadherin and vimentin in monolayers of control cells, TGF-β1-treated cells
and TGF-β1-treated Sema4C-siRNA cells. Cell nuclei were enhanced by staining of cell nuclei with propidium iodide for E-cadherin and DAPI for
Vimentin. Magnification ×400. (C) Representative fibronectin secretion in culture media of control cells, TGF-β1-treated cells and TGF-β1-treated
Sema4C-siRNA cells (n = 4). *P < 0.05 compared with control cells.
#P < 0.05 compared with TGF-β1-treated cells.
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Sema4C-mediated EMT [Figures 4A and 4C (III and VI)].
Fibronectin secretion of HKC cells was also regulated by
Sema4C. When HKC cells were transfected with Sema4C,
there was a significant increase in fibronectin accumulation
in culture supernatants (Figure 4D). However, treatment
with SB203580 inhibited the secretion of fibronectin pro-
tein compared with Sema4C-transfected cells (Figure 4D).
Those results indicate that Sema4C can phosphorylate p38
MAPK in cultured human tubular epithelial cells and
induce EMT.
To further confirm the relationship between Sema4C
and activation of p38 MAPK on tubules in vivo,w ee v a l -
uated sequential kidney sections from 5/6-nephrectomized
rats and patients with renal fibrosis. Sema4C expression in
tubules was highly correlated with p-p38 MAPK expres-
sion in these kidneys (Figure 5). In fibrotic kidney from
either rats or human beings, along with an increase in
Sema4C, phosphorylated p38 MAPK was over-expressed
in the renal epithelia, and the distribution patterns of phos-
phorylated p38 MAPK and Sema4C were highly congru-
ent in the renal tubules (Figure 5C–H). In contrast, tubules
in normal rats barely expressed either Sema4C or p-p38
MAPK (Figure 5A–B). These results suggest that Sema4C
is involved in TGF-β1-induced renal fibrosis via the p38
MAPK pathway.
Taken together, our results indicate that Sema4C directly
activates p38 kinase in TGF-β1-treated cells, and that
Sema4C-MAPK signalling pathway is important in TGF-
β1-induced EMT.
Discussion
The epithelial–mesenchymal transition (EMT) of tubular
epithelial cells is a critical process of renal tubulointersti-
tial fibrosis [2,18]. TGF-β1 signalling pathway plays a
central role in regulating tubular EMT [5,18]. TGF-β1
transduces cellular signals via heterotetrameric complexes
of type II (TβR-II) and type I (TβR-I) receptors [19]. The
binding of TGF-β1t oT βR-II leads to phosphorylation of
TβR-I and then activates receptor-activated (R) Smads
(Smad2 and Smad3) and triggers EMT [20]. However,
the activation of EMT is thought to occur through the sig-
nals arising not only from Smad2/3 but also those activated
in response to p38 MAPK [21–23]. Recent studies have
established a direct link between the TGF-β receptors
and p38 MAPK [10,21,22]. TGF-β1 enables src to phos-
phorylate TβR-II on Tyr284. Phosphorylated TβR-II func-
tions as an Src homology 2 (SH2) domain-binding site for
growth factor receptor-bound protein 2 (Grb2), leading to
substantial phosphorylation of p38 MAPK [21,22]. This,
in turn, triggers intracellular signalling pathways related
to EMT. Despite recent advances in understanding this
pathway, the molecular mechanisms that enable TGF-β1
to activate p38 MAPK remain to be fully elucidated.
In the current study, Sema4C, a transmembrane protein
and member of the semaphorin family, was reported to be
essential for the activation of p38 MAPK [11]. The cyto-
plasmic domain of Sema4C contains a proline-rich region
that may interact with Src homology 3 (SH3) domains and
mediate intracellular signalling via interaction with a SH3
domain-containing protein. The adapter protein Grb2 is
composed almost exclusively of SH3 domains [24]. Thus,
it is possible that Sema4C may recruit Grb2 to the cellular
membrane, promote association of TβR-II and Grb2, and
ultimately facilitate the activation of p38 MAPK. There-
fore, we postulated that Sema4C promote p38 MAPK sig-
nalling in the TGF-β1-induced renal tubular EMT.
The findings of our study support the hypothesis that
Sema4C plays an important role in mediating renal tubular
EMT through p38 MAPK signalling. Our in vivo experi-
ments indicated that Sema4C increased in the tubular epi-
thelial cells of fibrotic kidneys, and in vitro experiments
indicated that TGF-β1 treatment induced over-expression
of Sema4C in human tubular epithelial cells (HKC) accom-
panying characteristic changes of EMT. Loss of E-cadherin
(a cell adhesion molecule present in the membranes of most
epithelial cells) occurred, and this protein developed a dis-
continuous distribution along the cell perimeters. Vimentin,
Fig. 3. Depletion of Sema4C represses TGF-β1-induced activation of p38 MAPK. Representative western blot of phosphorylated p38 MAPK in control
cells, TGF-β1-treated cells and TGF-β1-treated Sema4C-siRNA cells. The histogram shows the average volume density of phosphorylated p38 MAPK
corrected for the loading control, total p38 MAPK (n = 4). *P < 0.05 compared with control cells.
#P < 0.05 compared with TGF-β1-treated cells.
Sema4C mediates TGF-β1 stimulation of EMT via p38 MAPK 1153a cytoskeletal protein in many mesenchymal cells, was also
induced. Fibronectin secretion, a consequence of EMT, was
significantly increased in HKC cell culture supernatants.
Over-expression of Sema4C, performed with a Sema4C-
transfected cell culture system, also remarkably accelerated
the differentiation of epithelial HKC into mesenchymal
cells. In addition, Sema4C siRNA knockdown in TGF-β1-
treatedHKCcellsmaintainedE-cadherin,blockedvimentin
expression and inhibited fibronectin secretion, suggesting
a delay of the EMT process. Taken together, these results
suggest that Sema4C contributes to TGF-β1-induced
EMT.
Haitao Wu et al. [11] have previously demonstrated that
p38 MAPK is a key element for Sema4C signalling, and
Fig. 4. Over-expression of human Sema4C promotes EMT via activation of p38 MAPK. (A) Representative western blots of Sema4C, E-cadherin and
vimentin in control cells, Sema4C-transfected cells and SB203580-treated Sema4C-transfected cells. The histogram shows the average volume density
corrected for the loading control, GAPDH (n = 4). *P < 0.05 compared with control cells.
#P < 0.05 compared with Sema4C-transfected cells. (B)
Representative western blot of phosphorylated p38 MAPK in control cells, Sema4C-transfected cells and SB203580-treated Sema4C-transfected cells.
The histogram shows the average volume density of phosphorylated p38 MAPK corrected for the loading control, total p38 (n = 4). *P < 0.05 compared
with control cells.
#P < 0.05 compared with Sema4C-transfected cells. (C) Representative confocal microscopy of E-cadherin and vimentin in
monolayers of control cells, Sema4C-transfected cells and SB203580-treated Sema4C-transfected cells. Cell nuclei were enhanced by staining of
cell nuclei with propidium iodide for E-cadherin and DAPI for vimentin. Magnification, ×400. (D) Representative fibronectin secretion in culture
media of control cells, Sema4C-transfected cells and SB203580-treated Sema4C-transfected cells (n = 4). *P < 0.05 compared with control cells.
#P < 0.05 compared with Sema4C-transfected cells.
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confirmed that p38 MAPK requires Sema4C for the regu-
lation of EMT. Sema4C initiates p38 MAPK phosphoryl-
ation in Sema4C-transfected cells, and SB203580 (a p38
MAPK inhibitor) suppresses the activation of p38 MAPK
and EMT. Knockdown of Sema4C dramatically impairs
the phosphorylation of p38 MAPK during TGF-β1 treat-
ment (Figure 3). Those results indicated that Sema4C
mediated TGF-β1-induced EMT through the activation
of p38 MAPK. Furthermore, we demonstrated in vivo that
the distribution pattern of phosphorylated p38 MAPK is
highly congruent with that of Sema4C in tubules of fibrot-
ic kidney (Figure 5). As tubular epithelial cells are the nat-
ural targets of TGF-β1 in vivo [17], this result further
supported that TGF-β1 exerts its fibrogenic effect through
Sema4C-mediated activation of p38 MAPK.
Our study provides the first evidence for this hypothesis
and shows that the TGF-β1 stimulation of tubular EMT
is intimately linked to the Sema4C and the associated
phosphorylation of p38 MAPK. From these findings,
we propose to identify the formation and distribution of
Sema4C–Grb2 complex and indicate its necessity for the
activation of p38 MAPK during TGF-β1 treatment in fu-
ture studies. Future studies are also needed to determine
whether therapeutic targeting of Sema4C may function in
alleviating the development of the TGF-β1-induced EMT.
Furthermore, the knockdown of Sema4C (Figure 2A–B) or
inhibition of p38 MAPK (Figure 4A, C) did not substantial-
ly preserve EMT, suggesting that other activated pathways
are involved. The crosstalk between Sema4C/p38 MAPK
and other intracellular signal transduction pathways and
the therapeutic strategy targeting multiple kinases may
need to be studied in the future.
In summary, the results presented here demonstrate that
TGF-β1-induced activation of p38 MAPK and EMT is
regulated by Sema4C in renal proximal tubular epithelial
Fig. 5. Immunohistochemistry of Sema4C and phosphorylated p38 MAPK on serial sections of rats or patients with renal fibrosis. Sema4C and p38
MAPK were co-expressed in tubules from rats or patients with tubulointerstitial fibrosis. These were representative photomicrographs from kidneyso f
sham rats immunostained with Sema4C (A) or p-p38 MAPK (B), 5/6-nephrectomized rats immunostained with Sema4C (C) or p-p38 MAPK (D),
patients with sclerosing glomerulonephritis immunostained with Sema4C (E)o rp - p 3 8M A P K( F) and patients with obstructive nephropathy
immunostained with Sema4C (G) or p-p38 MAPK (H). Magnification, ×200.
Sema4C mediates TGF-β1 stimulation of EMT via p38 MAPK 1155cells. Depletion of Sema4C inhibited activation of p38
MAPK and blocked TGF-β1-induced EMT. Our results in-
dicate the importance of Sema4C-MAPK signalling path-
way in the development and progression of renal fibrosis,
and thus suggest that this is a potential therapeutic target
for the treatment of renal fibrosis.
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